美国药典委员会 (USP) 标准品-免疫在线蚂蚁淘旗下平台-

当前位置：首页 > 新闻动态 >

热卖商品

USP/白芍去皮根干浸膏（500 mg）/1491605

USP/食品化学品法典在线2年订阅/2fc002

美国药典(美国药典委员会)//1042373

USP/USP Dictionary Online/3934707

新闻详情

美国药典委员会 (USP) 标准品

来自 : 发布时间：2025-06-30

货号：	U--
规格：	0.1 ml at 1 mg/ml

美国药典委员会 (USP) 是一家非营利性科研机构，为全世界生产、经销、使用的药品、食品成分和膳食补充剂的质量、纯度、鉴定和浓度设立标准。USP 的标准在美国由药品与食品管理局 (FDA) 强制实施，全世界有 130 多个国家/地区也在制定和采用这些标准。　　USP 标准由一家国际性组织开发和修订，该组织的 800 多名专业志愿者与 USP 一道按照严格的避免利益冲突的原则开展工作。自从 1820 年创立以来，USP 一直在帮助确保美国药品的质量。沿袭这一传统，USP 今天与许多国家的科学家、医疗保健从业者和监管机构协力保护全世界的公共健康。

U-1733119	Meso-Zeaxanthin (5x 30 mg) (Beta-Beta-Carotene-3,3-diol, (3R ,3 S)-)
U-1727053	Zolmitriptan Related Compound D (20 mg) ((S)-Ethyl 3-[2-(dimethylamino)ethyl]-5-[(2-oxooxazolidin-4-yl)methyl]-1H-indole-2-carboxylate)
U-1727031	Zolmitriptan Related Compound B (20 mg) ((S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol)
U-1727020	Zolmitriptan Related Compound A (20 mg) ((S)-4-({3-[2-(Methylamino)ethyl]-1H-indol-5-yl}methyl)oxazolidin-2-one)
U-1727018	Zolmitriptan R-Isomer (20 mg) ((R)-4-({3-[2-(Dimethylamino)ethyl]indol-5-yl}methyl)oxazolidin-2-one)
U-1727009	Zolmitriptan (150 mg)
U-1725036	Zonisamide Related Compound C (20 mg) (N-(benzisoxazol-3-ylmethylsulfonyl)-N,N-dimethylformimidamide)
U-1725014	Zonisamide Related Compound A (20 mg) (1,2-benzisoxazole-3-methanesulfonic acid sodium salt)
U-1725003	Zonisamide (200 mg)
U-1724838	Zoledronic Acid Related Compound A (30 mg) (2-(1H-Imidazol-1-yl)acetic acid)
U-1724827	Zoledronic Acid (150 mg)
U-1724805	Zolazepam Hydrochloride (500 mg)
U-1724769	Zinc Sulfate (1 g) (AS)
U-1724747	Zinc Oxide (2 g) (AS)
U-1724689	Zileuton Related Compound C (50 mg) (1-Benzo[b]thien-2-ylethanone)
U-1724678	Zileuton Related Compound B (50 mg) (2-(Benzo[b]thien-2-oyl)benzo[b]thiophene)
U-1724667	Zileuton Related Compound A (50 mg) (N-(1-Benzo[b]thien-2-ylethyl) urea)
U-1724656	Zileuton (150 mg)
U-1724543	Zidovudine Related Compound D (50 mg) ([1-(2-Deoxy-beta-D-ribofuranosyl)]thymine)
U-1724532	Zidovudine Related Compound C (100 mg) (thymine)
U-1724521	Zidovudine Related Compound B (25 mg) (3-chloro-3-deoxythymidine)
U-1724500	Zidovudine (400 mg)
U-1724452	Ziprasidone Related Compound D (10 mg) (3-(Benzo[d]isothiazol-3-yl)-5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one)
U-1724441	Ziprasidone Related Compound C (10 mg) (5,5-Bis(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6,6-dichloro-3-hydroxy-3,3-biindoline-2,2-dione)
U-1724420	Ziprasidone Related Compound B (10 mg) (5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindoline-2,3-dione)
U-1724419	Ziprasidone Related Compound A (10 mg) (3-(Piperazin-1-yl)benzo[d]isothiazole monohydrochloride)
U-1724408	Ziprasidone Hydrochloride (200 mg)
U-1724317	Zalcitabine Related Compound A (50 mg) (2,3-Didehydro-2,3-dideoxycytidine)
U-1724306	Zalcitabine (200 mg)
U-1722005	Xylose (1 g)
U-1720600	Xylitol (1 g)
U-1720407	Xylazine (200 mg)
U-1720203	Xanthone (100 mg)
U-1720000	Xanthanoic Acid (100 mg)
U-1719532	Withanoside IV (15 mg)
U-1719500	Withanolide A (15 mg)
U-1719102	Warfarin Related Compound A (50 mg) (3-(o-hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one)
U-1719000	Warfarin (200 mg)
U-1718041	Voriconazole Related Compound D (10 mg) ((2RS,3SR)-2-(2,4-difluorophenyl)-3-(pyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)
U-1718039	Voriconazole Related Compound C (10 mg)
U-1718020	Voriconazole Related Compound B (10 mg) ((2S, 3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)
U-1718019	Voriconazole Related Compound A (10 mg) ((2RS, 3RS)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)
U-1717708	Vitexin (25 mg)
U-1716002	Retinyl Acetate (Vitamin A) (10 ampuls x 0.5 g)
U-1715000	Viomycin Sulfate (200 mg)
U-1714652	Vinpocetine Related Compound D (30 mg) (ethyl (12RS,13aRS,13bRS)-13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate)
U-1714641	Vinpocetine Related Compound C (30 mg) (ethyl (13aS,13bS)-13a-ethyl-10-methoxy-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate)
U-1714620	Vinpocetine Related Compound B (30 mg) (methyl (13aS,13bS)-13a-ethyl-9-methoxy-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate)
U-1714619	Vinpocetine Related Compound A (30 mg) (ethyl (12RS,13aSR,13bSR)-13a-ethyl-12-hydroxy-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate)
U-1714608	Vinpocetine (100 mg)
U-1712045	Vigabatrin Related Compound E (30 mg) (2-(2-aminobut-3-enyl)malonic acid)
U-1712023	Vigabatrin Related Compound B (30 mg) ((E)-2-(2-aminoethyl)but-2-enoic acid hydrochloride)
U-1712012	Vigabatrin Related Compound A (50 mg) (5-vinylpyrrolidin-2-one)
U-1712001	Vigabatrin (100 mg)
U-1711508	Vidarabine (200 mg)
U-1711472	Verteporfin Related Compound A (50 mg) ((+/-)18-Ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-23H,25H-benzo[b]prophine-9,13-dipropanoic acid)
U-1711461	Verteporfin (200 mg)
U-1711440	Verapamil Related Compound F (150 mg) (3,4-Dimethoxybenzyl alcohol)
U-1711439	Verapamil Related Compound E (50 mg) (3,4-dimethoxybenzaldehyde)
U-1711428	Verapamil Related Compound D (50 mg) (5,5-[[2-(3,4)dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)-2-(1-methylethyl)pentanenitrile] hydrochloride)
U-1711304	Verapamil Related Compound A (50 mg) (3,4-Dimethoxy-alpha-[3-(methylamino)propyl]-alpha-(1-methylethyl)-benzeneacetonitrile monohydrochloride)
U-1711279	Venlafaxine Related Compound A (10 mg) (1-(1-(4-Methoxyphenyl)-2-(methylamino)ethyl)cyclohexanol hydrochloride)
U-1711268	Venlafaxine Hydrochloride (100 mg)
U-1711224	Vecuronium Bromide Related Compound F (15 mg) (Piperidinium,1-[(2beta,3alpha,5alpha,16beta,17beta)-17-acetyloxy-3-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide)
U-1711202	Verapamil Hydrochloride (200 mg)
U-1711188	Vecuronium Bromide Related Compound C (15 mg) (Piperidinium,1-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-dihydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide)
U-1711177	Vecuronium Bromide Related Compound B (15 mg) (Piperidinium, 1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide)
U-1711166	Vecuronium Bromide Related Compound A (25 mg) (3alpha, 17beta-diacetyl-oxy-2beta, 16beta-bispiperidinyl-5alpha-androstan)
U-1711155	Vecuronium Bromide (50 mg)
U-1711133	Lypressin (2.2 mg) (8-L-lysine vasopressin) (COLD SHIPMENT REQUIRED)
U-1711100	Vasopressin (1.71 mg) (8-L-arginine vasopressin) (COLD SHIPMENT REQUIRED)
U-1711031	Vasicine (20 mg)
U-1711009	Vanillin Melting Point Standard (1 g) (Approximately 82 degrees)
U-1710006	Vanillin (200 mg)
U-1709018	Vancomycin B with Monodechlorovancomycin (300 mg)
U-1709007	Vancomycin Hydrochloride (4 vials, each vial contains 99,300 mcg of vancomycin activity)
U-1708795	Valsartan Related Compound C (10 mg) (N-valeryl-N-{[2-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine benzyl ester)
U-1708773	Valsartan Related Compound A (10 mg) ((R)-N-Valeryl-N-([2-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl)-valine)
U-1708784	Valsartan Related Compound B (10 mg) (N-butyryl-N-{[2-(1H-tetrazole-5-yl)-biphenyl-4-yl]methyl}-L-valine)
U-1708762	Valsartan (350 mg)
U-1708751	Valrubicin Resolution Mixture (25 mg) (valrubicin spiked with seven related substances)
U-1708730	Valrubicin (100 mg)
U-1708729	Valproic Acid Related Compound A (0.25 mL) (diallyl acetic acid)
U-1708718	Valproic Acid Related Compound B (25 mg) ((2RS)-2-(1-methylethyl)pentanoic acid)
U-1708707	Valproic Acid (500 mg)
U-1708503	L-Valine (200 mg)
U-1708015	D-Valganciclovir (10 mg) (2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-methoxy]-3-hydroxypropyl D-valine ester monohydrochloride)
U-1708004	Valganciclovir Hydrochloride (500 mg)
U-1707931	Powdered Valerian Extract (1 g)
U-1707908	Valerenic Acid (15 mg)
U-1707883	Valacyclovir Related Compound F (25 mg) (2-hydroxyethyl valinate para-toluenesulfonate salt)
U-1707872	Valacyclovir Related Compound E (25 mg) (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy)carbonyl]-L-valinate)
U-1707861	Valacyclovir Related Compound D (15 mg) (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-L-valinate)
U-1707855	Valacyclovir Related Compound C (10 mg) (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-methyl-L-valinate hydrochloride)
U-1707839	Valacyclovir Hydrochloride (200 mg)
U-1707806	Ursodiol (125 mg)
U-1707770	Ursolic Acid (25 mg)
U-1707114	Uridine (15 mg)
U-1706701	Urea C 13 (150 mg)
U-1706698	Urea (200 mg)
U-1705800	Uracil Arabinoside (50 mg)
U-1705753	Uracil (15 mg)
U-1705505	Undecylenic Acid (200 mg)
U-1705323	Ubidecarenone Related Compound A (15 mg) (Coenzyme Q9)(COLD SHIPMENT REQUIRED)
U-1705312	Ubidecarenone for System Suitability (25 mg) (COLD SHIPMENT REQUIRED)
U-1705301	Ubidecarenone (200 mg) (COLD SHIPMENT REQUIRED)
U-1705006	L-Tyrosine (500 mg)
U-1704003	Tyloxapol (600 mg)
U-1703850	Tylosin Tartrate (100 mg)
U-1703805	Tylosin (250 mg)
U-1702008	Tubocurarine Chloride (175 mg)
U-1700523	Tryptophan Related Compound B (25 mg) (N-Acetyl-L-Tryptophan)
U-1700512	Tryptophan Related Compound A (15 mg) (1,1-ethylidene-bis(L-tryptophan))
U-1700501	L-Tryptophan (200 mg)
U-1700002	Trypsin Crystallized (300 mg) (COLD SHIPMENT REQUIRED)
U-1699322	Trospium Chloride Related Compound B (20 mg) ((1R,3r,5S)-8-azabicyclo[3.2.1]octan-3-yl hydroxydiphenylacetate)
U-1699311	Trospium Chloride Related Compound A (20 mg) (Benzilic Acid) (International Restricted Sales Item)
U-1699300	Trospium Chloride (100 mg)

温馨提示：不可用于临床治疗。

本文链接： http://usp.immuno-online.com/view-1475371966.html

发布于： 2025-06-30 阅读（）

没有了